PMID: 42574969

A phase II study of androgen receptor inhibition by darolutamide in combination with leuprolide acetate and exemestane in recurrent adult-type ovarian granulosa cell tumor.

Hopp Elizabeth E, Enserro Danielle, Campos Susana, Chitiyo Viola, Huang Gloria, Lankes Heather, Crane Erin K, Hoekstra Anna, Siedel Jean, Richardson Debra L

Gynecologic oncology · 2026

Vol. 212, pp. 98-105

View on PubMed DOI

This entry links to third-party literature. For research use only.

For research use only. This index links to third-party literature. Nothing here constitutes medical advice.